Rita L. Hui

4.8k total citations · 1 hit paper
66 papers, 2.3k citations indexed

About

Rita L. Hui is a scholar working on Oncology, Orthopedics and Sports Medicine and Surgery. According to data from OpenAlex, Rita L. Hui has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 15 papers in Orthopedics and Sports Medicine and 11 papers in Surgery. Recurrent topics in Rita L. Hui's work include Bone health and treatments (12 papers), Bone and Joint Diseases (12 papers) and Bone health and osteoporosis research (12 papers). Rita L. Hui is often cited by papers focused on Bone health and treatments (12 papers), Bone and Joint Diseases (12 papers) and Bone health and osteoporosis research (12 papers). Rita L. Hui collaborates with scholars based in United States, Australia and Spain. Rita L. Hui's co-authors include Michele M. Spence, Gerald Levy, David Campen, Stanford Shoor, David J. Graham, Wayne A. Ray, Craig Cheetham, Joan C. Lo, Felice O’Ryan and Dan C. Martin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Rita L. Hui

61 papers receiving 2.2k citations

Hit Papers

Risk of acute myocardial infarction and sudden cardiac de... 2005 2026 2012 2019 2005 200 400 600

Peers

Rita L. Hui
Andrea M. Burden Switzerland
K. Jack Ishak United States
Melvin Olson Switzerland
Sally Wade United States
Lisa M. Hess United States
Diana Brixner United States
Nancy C. Dolan United States
Rita L. Hui
Citations per year, relative to Rita L. Hui Rita L. Hui (= 1×) peers Liisa Jaakkimainen

Countries citing papers authored by Rita L. Hui

Since Specialization
Citations

This map shows the geographic impact of Rita L. Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita L. Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita L. Hui more than expected).

Fields of papers citing papers by Rita L. Hui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita L. Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita L. Hui. The network helps show where Rita L. Hui may publish in the future.

Co-authorship network of co-authors of Rita L. Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Rita L. Hui. A scholar is included among the top collaborators of Rita L. Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita L. Hui. Rita L. Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Nathan P., et al.. (2025). Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapy. Blood Coagulation & Fibrinolysis. 36(3). 71–77. 1 indexed citations
2.
Sharma, Kavita, Nina Shah, Juraj Kavecansky, et al.. (2025). Reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer. Gynecologic Oncology. 196. 36–41. 1 indexed citations
3.
Sharma, Kavita, Nina Shah, Michael A. Bookman, et al.. (2024). Outcomes of reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer.. Journal of Clinical Oncology. 42(16_suppl). 5588–5588.
4.
Wong, Helen, Vivian Nguyen, Fang Niu, et al.. (2024). Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study. BioDrugs. 38(4). 601–610.
6.
Clark, Nathan P., et al.. (2023). Safety of direct oral anticoagulant use in patients taking verapamil or diltiazem. Heart Rhythm. 20(12). 1793–1795. 4 indexed citations
7.
Clark, Nathan P., et al.. (2022). Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min. Journal of Thrombosis and Thrombolysis. 55(2). 355–364. 3 indexed citations
8.
Niu, Fang, et al.. (2021). Real world outcomes related to providing an annual supply of short-acting hormonal contraceptives. Contraception. 107. 58–61. 3 indexed citations
9.
Lo, Joan C., Romain Neugebauer, Bruce Ettinger, et al.. (2020). Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskeletal Disorders. 21(1). 801–801. 7 indexed citations
10.
Rodríguez‐Abreu, Delvys, M.C. Garassino, Emilio Esteban, et al.. (2018). KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?. Annals of Oncology. 29. ix164–ix164. 4 indexed citations
11.
Lo, Joan C., Bruce Ettinger, Bonnie H. Li, et al.. (2017). Trends in bisphosphonate initiation within an integrated healthcare delivery system.. PubMed. 23(12). e421–e422. 1 indexed citations
12.
Spence, Michele M., Rita L. Hui, Jennifer Chang, et al.. (2017). Treatment Patterns and Overall Survival Associated with First-Line Systemic Therapy for Patients with Advanced Non-Small Cell Lung Cancer. Journal of Managed Care & Specialty Pharmacy. 23(2). 195–205. 13 indexed citations
13.
Spence, Michele M., et al.. (2016). The Risk of Pneumonia in Older Adults Using Nonbenzodiazepine Hypnotics. Journal of Managed Care & Specialty Pharmacy. 22(8). 932–938. 10 indexed citations
14.
Levin, Victor A., et al.. (2015). Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma. Journal of Neuro-Oncology. 122(1). 145–150. 53 indexed citations
15.
Lo, Joan C., et al.. (2012). Treatment of Vitamin D Deficiency Within a Large Integrated Health Care Delivery System. Journal of Managed Care Pharmacy. 18(7). 497–505. 8 indexed citations
16.
Lo, Joan C., Susie Y. Huang, Bruce Ettinger, et al.. (2012). Clinical correlates of atypical femoral fracture. Bone. 51(1). 181–184. 99 indexed citations
17.
Lo, Joan C., Felice O’Ryan, Nancy P. Gordon, et al.. (2009). Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure. Journal of Oral and Maxillofacial Surgery. 68(2). 243–253. 361 indexed citations
18.
Chan, James, Rita L. Hui, & Michele M. Spence. (2007). Effects on Resource Utilization of Adding Salmeterol in Combination or Separately to Inhaled Corticosteroids. Journal of Managed Care Pharmacy. 13(1). 21–27. 13 indexed citations
19.
Hsu, John, Mary Price, Jie Huang, et al.. (2006). Unintended Consequences of Caps on Medicare Drug Benefits. New England Journal of Medicine. 354(22). 2349–2359. 284 indexed citations
20.
Spence, Michele M., Rita L. Hui, & James Chan. (2006). Cost Reduction Strategies Used by Elderly Patients With Chronic Obstructive Pulmonary Disease to Cope With a Generic-Only Pharmacy Benefit. Journal of Managed Care Pharmacy. 12(5). 377–382. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026